BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10382886)

  • 1. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    Mayer I; Nagy E
    J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-antibiotic and synergic effects of fluoroquinolones and ceftazidime in combination against Pseudomonas strains.
    Mayer I; Nagy E
    Acta Biol Hung; 2001; 52(2-3):241-8. PubMed ID: 11426858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
    Mayer I; Nagy E
    APMIS; 2000 Apr; 108(4):261-6. PubMed ID: 10843412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa.
    Sood P; Mandal A; Mishra B
    Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins & newer cephalosporins against Pseudomonas species.
    Paul K; De PK; Bhattacharya S
    Indian J Med Res; 1992 May; 95():136-8. PubMed ID: 1506063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
    Gerçeker AA; Gürler B
    J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa.
    Song W; Woo HJ; Kim JS; Lee KM
    Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Burgess DS; Hastings RW
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
    Visalli MA; Bajaksouzian S; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2002-5. PubMed ID: 9687397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
    Fosse T; Soussy CJ; Duval J
    Pathol Biol (Paris); 1983 Jun; 31(6):483-7. PubMed ID: 6348654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    Anan N; Toba S; Ito A; Nakamura R; Tsuji M
    Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
    Otsuki M; Nishino T
    J Antimicrob Chemother; 1996 Nov; 38(5):771-6. PubMed ID: 8961046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.